HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $353,421 | -10.3% | 343,127 | +1.1% | 0.00% | 0.0% |
| Q2 2023 | $393,790 | -63.0% | 339,474 | -51.9% | 0.00% | -60.0% |
| Q1 2023 | $1,065,572 | +154.2% | 705,677 | +320.9% | 0.01% | +150.0% |
| Q4 2022 | $419,133 | -42.6% | 167,653 | -3.1% | 0.00% | -50.0% |
| Q3 2022 | $730,000 | +182.9% | 173,053 | +985.7% | 0.00% | +300.0% |
| Q1 2021 | $258,000 | -52.5% | 15,940 | -37.9% | 0.00% | -50.0% |
| Q4 2020 | $543,000 | +42.5% | 25,650 | -0.2% | 0.00% | 0.0% |
| Q3 2020 | $381,000 | +5.8% | 25,700 | +5.0% | 0.00% | 0.0% |
| Q2 2020 | $360,000 | +102.2% | 24,470 | +61.1% | 0.00% | +100.0% |
| Q1 2020 | $178,000 | -51.1% | 15,194 | +2.0% | 0.00% | -50.0% |
| Q1 2019 | $364,000 | -28.8% | 14,890 | -24.4% | 0.00% | -33.3% |
| Q4 2018 | $511,000 | +100.4% | 19,690 | +144.6% | 0.00% | +200.0% |
| Q3 2018 | $255,000 | – | 8,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |